Is the C-C Motif Ligand 2–C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is the C-C Motif Ligand 2–C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 23, Pages 9328
Publisher
MDPI AG
Online
2020-12-08
DOI
10.3390/ijms21239328
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes
- (2020) Thomas M. Pausch et al. Scientific Reports
- Increased Vascular Adhesion Protein 1 (VAP-1) Levels Are Associated with Alternative M2 Macrophage Activation and Poor Prognosis for Human Gliomas
- (2020) Shu-Jyuan Chang et al. Diagnostics
- Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small-Cell Lung Carcinoma
- (2020) Xiang Zheng et al. CANCER RESEARCH
- The CCL20-CCR6 Axis in Cancer Progression
- (2020) Suguru Kadomoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor Cells Interleukin-22 Expression Associates with Elevated Tumor-Associated Macrophages Infiltrating and Poor Prognosis in Patients with Breast Cancer
- (2020) Jidong Zhao et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Targeting a positive regulatory loop in the tumor-macrophage interaction impairs the progression of clear cell renal cell carcinoma
- (2020) Chao Wang et al. CELL DEATH AND DIFFERENTIATION
- Prognostic significance of tumor-associated macrophages in patients with nasopharyngeal carcinoma
- (2020) Ya-Lian Chen MEDICINE
- Prognostic value of some inflammatory markers in patients with lymphoma
- (2019) Nahla Hamed Anber et al. BIOSCIENCE REPORTS
- The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte Recruitment
- (2019) Daniel P. Regan et al. JOURNAL OF IMMUNOLOGY
- CCL2 promotes cell migration by inducing epithelial‐mesenchymal transition in oral squamous cell carcinoma
- (2019) Zihang Ling et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma
- (2019) Marcus Noel et al. INVESTIGATIONAL NEW DRUGS
- PIPKIγ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling
- (2019) JunLi Xue et al. Journal of Immunology Research
- Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients
- (2019) Takumi Kishimoto et al. BMC CANCER
- Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
- (2019) Dongbo Li et al. CANCER SCIENCE
- Interleukin‐33‐nuclear factor‐κB‐CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells
- (2019) Ying Yue et al. CANCER SCIENCE
- Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer
- (2019) Eleni-Kyriaki Vetsika et al. Cells
- Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2
- (2018) Yuan-Chin Tsai et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A guide to chemokines and their receptors
- (2018) Catherine E. Hughes et al. FEBS Journal
- CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer
- (2018) Wenxia Xu et al. International Journal of Biological Sciences
- Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts.
- (2018) David Linehan et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration
- (2018) Bianca Cioni et al. Molecular Oncology
- CCL2 influences the sensitivity of lung cancer A549 cells to docetaxel
- (2018) Ting Wang et al. Oncology Letters
- High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma
- (2018) Lei Li et al. Thoracic Cancer
- Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients
- (2018) Erin E. Talbert et al. Journal of Cachexia Sarcopenia and Muscle
- Recruitment of CCR2+ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer
- (2018) Julie G Grossman et al. OncoImmunology
- Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma
- (2018) Yan-Li Li et al. ANNALS OF HEMATOLOGY
- CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells
- (2018) Ariunbold Natsagdorj et al. CANCER SCIENCE
- CCL2 is a vascular permeability factor inducing CCR2-dependent endothelial retraction during lung metastasis
- (2018) Marko Roblek et al. MOLECULAR CANCER RESEARCH
- Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells
- (2018) Hiroaki Iwamoto et al. PROSTATE
- High expression of CCL2 in tumor cells and abundant infiltration with CD14 positive macrophages predict early relapse in breast cancer
- (2018) Marja Heiskala et al. VIRCHOWS ARCHIV
- Perioperative cytokine levels portend early death after pancreatectomy for ductal adenocarcinoma
- (2017) Heather L. Lewis et al. JOURNAL OF SURGICAL ONCOLOGY
- CCL2 expression correlates with Snail expression and affects the prognosis of patients with gastric cancer
- (2017) Jia Zhang et al. PATHOLOGY RESEARCH AND PRACTICE
- Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells
- (2017) Jun An et al. Oncotarget
- FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling
- (2016) Xuguang Yang et al. CANCER RESEARCH
- Elevated level of some chemokines in plasma of gastric cancer patients
- (2016) Monika Baj-Krzyworzeka et al. Central European Journal of Immunology
- Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma
- (2016) Anusha Kalbasi et al. CLINICAL CANCER RESEARCH
- Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis
- (2016) Y.W. Pan et al. GENETICS AND MOLECULAR RESEARCH
- Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
- (2016) Timothy M Nywening et al. LANCET ONCOLOGY
- Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers
- (2016) Min Yao et al. MODERN PATHOLOGY
- CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma
- (2016) Zewei Wang et al. Oncotarget
- CCL2/EGF positive feedback loop between cancer cells and macrophages promotes cell migration and invasion in head and neck squamous cell carcinoma
- (2016) Lu Gao et al. Oncotarget
- Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22–CCR4 axis
- (2016) Aerken Maolake et al. Oncotarget
- CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
- (2016) Ryuichiro Arakaki et al. Cancer Medicine
- Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer
- (2015) Faruk Tas et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
- (2015) Takanori Kitamura et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Macrophages and cancer: from mechanisms to therapeutic implications
- (2015) Renato Ostuni et al. TRENDS IN IMMUNOLOGY
- Increased expression of C-C motif ligand 2 associates with poor prognosis in patients with gastric cancer after gastrectomy
- (2015) Hao Liu et al. TUMOR BIOLOGY
- Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer
- (2015) Kouji Izumi et al. Oncotarget
- Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals
- (2015) Qun Rao et al. Oncotarget
- CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
- (2015) Eunyoung Chun et al. Cell Reports
- Chemokine Receptor-Specific Antibodies in Cancer Immunotherapy: Achievements and Challenges
- (2015) Maria Vela et al. Frontiers in Immunology
- Fibroblast heterogeneity in the cancer wound
- (2014) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
- (2014) Francois Moisan et al. Molecular Oncology
- Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
- (2014) Laura Bonapace et al. NATURE
- A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
- (2014) Haihui Lu et al. NATURE CELL BIOLOGY
- The CCL2/CCR2 axis enhances IL-6-induced epithelial-mesenchymal transition by cooperatively activating STAT3-Twist signaling
- (2014) Wei Chen et al. TUMOR BIOLOGY
- Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia
- (2014) Lei-Lei Tao WORLD JOURNAL OF GASTROENTEROLOGY
- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
- (2013) Shahneen K. Sandhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
- (2013) D. E. Sanford et al. CLINICAL CANCER RESEARCH
- Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
- (2013) Kouji Izumi et al. EMBO Molecular Medicine
- Identification of Serum Monocyte Chemoattractant Protein-1 and Prolactin as Potential Tumor Markers in Hepatocellular Carcinoma
- (2013) Who-Whong Wang et al. PLoS One
- Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling
- (2013) T-H Lin et al. Cell Death & Disease
- Regulation of Monocyte Chemoattractant Protein-1 Through Angiotensin II Type 1 Receptor in Prostate Cancer
- (2012) Suguru Shirotake et al. AMERICAN JOURNAL OF PATHOLOGY
- Endothelial CCR2 Signaling Induced by Colon Carcinoma Cells Enables Extravasation via the JAK2-Stat5 and p38MAPK Pathway
- (2012) Monika Julia Wolf et al. CANCER CELL
- CCL2 is critical for immunosuppression to promote cancer metastasis
- (2012) Chie Kudo-Saito et al. CLINICAL & EXPERIMENTAL METASTASIS
- Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells
- (2012) Hsiao-Ying Chiu et al. CYTOKINE
- Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
- (2012) Jun Panee CYTOKINE
- Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
- (2012) Kenneth J. Pienta et al. INVESTIGATIONAL NEW DRUGS
- The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial–mesenchymal transition of peritoneal mesothelial cells
- (2012) Sun Ha Lee et al. LABORATORY INVESTIGATION
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
- (2012) Qiong-wen Zhang et al. PLoS One
- CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-κB signaling pathway
- (2011) Chih-Hsin Tang et al. BIOCHEMICAL PHARMACOLOGY
- Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
- (2011) Valerie Chew et al. GUT
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Macrophage chemotactic protein-1 mRNA levels in non-Hodgkin lymphoma
- (2010) Toni Valković et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Serum CCL2 and serum TNF-α – Two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma
- (2010) Xing Lu et al. EUROPEAN JOURNAL OF CANCER
- Tumor Cell-Microenvironment Interaction Models Coupled with Clinical Validation Reveal CCL2 and SNCG as Two Predictors of Colorectal Cancer Hepatic Metastasis
- (2009) H. Hu et al. CLINICAL CANCER RESEARCH
- Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells
- (2009) Maylis Dagouassat et al. INTERNATIONAL JOURNAL OF CANCER
- Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases
- (2009) Yoshidome INTERNATIONAL JOURNAL OF ONCOLOGY
- Angiotensin II Regulates the Expression of Monocyte Chemoattractant Protein-1 in Pancreatic Cancer Cells
- (2009) Navdeep Chehl et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
- (2009) Satish L. Deshmane et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity
- (2009) David Z. Qian et al. PROSTATE
- The Expression of Monocyte Chemotactic Protein-1 in Papillary Thyroid Carcinoma Is Correlated with Lymph Node Metastasis and Tumor Recurrence
- (2008) Katsuhiro Tanaka et al. THYROID
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search